Method for determining antibiotic sensitivity using Raman imaging technology
Monitoring the glucose-d7 metabolic activity of bacteria at the single cell level through ultraspectral stimulated Raman scattering imaging technology, solving the problems of long detection time and weak signal in the prior art, and achieving rapid and accurate antibiotic sensitivity to all bacteria Sexual testing is suitable for a variety of bacteria and determines the sensitivity and minimum inhibitory concentration of bacteria within 30 minutes.
Patent Information
- Application Number
- CN201880058493.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2017-09-08
- Filing Date
- 2018-09-10
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2038-09-10
AI Technical Summary
Existing antibiotic sensitivity detection methods have long detection time for bacteria and are only suitable for specific bacteria. They have weak signals, making it difficult to quickly and accurately monitor bacterial metabolic activity, especially their response to antibiotics, at the level of a single cell.
Monitor glucose-d7 metabolic activity in bacteria at the single cell level using ultraspectral stimulated Raman scattering (SRS) imaging technology, combined with improved sample preparation methods and Raman imaging systems, including dual-output femtosecond pulsed lasers and acousto-optical The modulator can determine the antibiotic sensitivity and minimum inhibitory concentration of bacteria within 30 minutes.
Fast and accurate antibiotic sensitivity detection for all bacteria is achieved, the sample enrichment time is reduced, suitable for a variety of bacteria, and the metabolic response can be monitored at the level of a single cell, significantly improving detection efficiency and signal-to-noise ratio.
Smart Images

Figure CN111133295B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a method for detecting metabolic activity of living bacteria, in particular to a method for detecting antibiotic sensitivity through a hyperspectral stimulated Raman scattering microscope. Background Art
[0002] The widespread use and abuse of antibiotics to combat various bacterial infections has led to an increase in the number of drug-resistant bacteria. Therefore, for specific infectious diseases, it is particularly important to analyze the antibiotic response of specific bacteria through antibiotic sensitivity testing (AST). Depending on the type of bacteria, conventional AST usually uses agar plates and broth dilution methods for bacterial culture, which generally takes at least 16-24 hours. Although new technologies are being developed for rapid detection, they are only applicable to specific bacteria or require time-consuming sample enrichment, which has certain limitations.
[0003] Raman spectroscopy, a non-standard quantitative technique for measuring molecular vibrations, has been applied to the rapid detection of bacterial AST. Raman peaks have been used as a biomarker in the field of fingerprints or deuterated water D2O metabolic absorption to characterize the response of bacteria to antibiotic treatment. However, due to the small cross-sectional area, the signal generated by Raman spectroscopy is weak, so a large amount of sample is required or a long integration time is required for each cell. Using metal colloids or rough metal surfaces, Raman signals can be enhanced by surface enhanced Raman spectroscopy (SERS). With the change of antibiotic treatment, SERS has been applied to the rapid detection of AST based on Raman peaks, but SERS requires a substrate and the signal changes greatly, which cannot be used in practice.
[0004] Coherent Raman scattering microscopy includes coherent anti-Stokes Raman scattering (CARS) and stimulated Raman scattering (SRS) microscopy, which significantly improves the signal compared to spontaneous Raman scattering. Unlike CARS, SRS microscopy does not have non-resonant background and has been applied to metabolic imaging of cells, tissues and model organisms. However, SRS is not completely background-free. Hyperspectral stimulated Raman scattering (SRS) can record spectra at each pixel to distinguish SRS signals from the background, including those due to nonlinear absorption and cross-phase modulation.
[0005] Imaging the metabolic activity of single bacteria remains highly challenging. The size of bacteria (about 1 μm in diameter) is much smaller than that of mammalian cells (about 10 μm), approaching the spatial resolution of CARS or SRS microscopy. In addition, CD Raman signals are much weaker than CH signals, so an improved AST method is needed. Preferably, this method does not require extended sample enrichment time and is applicable to a variety of bacteria at the single cell level. Summary of the invention
[0006] In one aspect, the present invention relates to a rapid antibiotic susceptibility test (AST) method applicable to all bacteria.
[0007] On the other hand, the present invention relates to a method for monitoring glucose-d7 metabolic activity in bacteria at the single cell level using hyperspectral stimulated Raman scattering (SRS) imaging technology.
[0008] On the other hand, the present invention relates to a rapid (AST) method applicable to all bacteria, which uses hyperspectral stimulated Raman scattering (SRS) imaging technology to monitor glucose-d7 metabolic activity in living bacteria at the single cell level. This method can use other nutrient sources similarly, such as D2O. Vancomycin sensitive (VSE) and resistant (VRE) enterococci can be used as models, and SRS imaging can be used to detect bacteria at the single cell level and quantitatively monitor their metabolic activity, and the metabolic response to antibiotic treatment can also be detected, thereby determining bacterial sensitivity and minimum inhibitory concentration (MIC) within 30 minutes. Similarly, the imaging method can also be applied to other antibiotics with different antibacterial or bactericidal mechanisms. Since glucose is a common carbon source for bacterial production, we can reasonably predict that this method can be applicable to a variety of bacteria.
[0009] In another aspect, the invention relates to a sample preparation method suitable for improved bacterial culture and imaging setup that maximizes the signal-to-noise ratio for a more consistent image processing process.
[0010] On the other hand, the present application relates to a Raman imaging system for rapid AST detection, wherein the Raman imaging system includes a dual-output femtosecond pulse laser, the dual-output femtosecond pulse laser includes a pump beam and a Stokes beam, wherein the path of the Stokes beam is modulated by an acousto-optic modulator, and the pump beam path includes a translation stage for tuning the delay between the pump beam and the Stokes beam. A combiner, the combiner is used to combine the pump beam and the Stokes beam. A chirp device, the chirp device is used to form different pulse durations between the pump beam and the Stokes beam. The laser scanning microscope also includes an objective lens that can focus the pump beam and the Stokes beam on the sample. In addition, the system may include an oil condenser for collecting laser light from the sample. The system may use one or more filters located after the condenser and suitable for filtering out the Stokes beam. A photodiode for detecting the pump beam may be located after the filter. A lock-in amplifier is used to extract pump beam signal loss. BRIEF DESCRIPTION OF THE DRAWINGS
[0011] To facilitate understanding of the features, benefits and implementations of the present application, please refer to the following published descriptions of systems and processes, in which:
[0012] Figure 1A A schematic diagram of an exemplary hyperspectral stimulated Raman scattering (SRS) establishment process of the present application;
[0013] Figure 1B A schematic diagram of the delay between the chirped pump beam and the Stokes beam in this application;
[0014] Figure 2A Schematic diagram of the antibiotic susceptibility testing (AST) process for this application;
[0015] Figure 2B For this application, whether vancomycin-sensitive and -resistant enterococci should be treated with 20 μg / ml vancomycin in the CD vibration zone (2178 cm -1 )’s hyperspectral stimulated Raman scattering (SRS) imaging data;
[0016] Figure 2C Hyperspectral stimulated Raman scattering (SRS) spectral data of susceptible bacteria for this application;
[0017] Figure 2D Hyperspectral stimulated Raman scattering (SRS) spectral data of drug-resistant bacteria for this application;
[0018] Figure 3 AD is the multivariate curve resolution (MCR) analysis data of the present application using hyperspectral SRS imaging data to separate the CD components of bacteria from the gel background. Figure 3 A is the SRS image of the CD vibration area of bacteria deposited on agarose gel; Figure 3 B is the MRC output spectra of glucose-d7 and gel components; Figure 3 C is the gel composition after multivariate curve resolution (MCR) analysis; Figure 3 D is the glucose-d7 component after multivariate curve resolution (MCR) analysis;
[0019] Figure 4 AB is the cross-phase modulation noise result of SRS imaging in this application;
[0020] Figure 5A -C is the result of measuring MIC using SRS metabolic imaging method in this application;
[0021] Figure 6 AD is the result of the change of bacteria in the CD vibration zone over time when the bacteria are cultured in a medium containing glucose-d7 under the condition of whether 20 μg / ml vancomycin is used in this application;
[0022] Figure 7 A is the application of hyperspectral SRS at 2150cm -1 The imaging results at
[0023] Figure 7 B is the graphic result of the spectrum corresponding to the 1M glucose-d7 solution in the CD region of the present application;
[0024] Figure 8 The spontaneous Raman spectra of vancomycin-sensitive enterococci (VSE) in the present application in normal culture medium and 2% glucose-d7 culture medium;
[0025] Fig. 9 AB are graphical representations of the bacterial growth test results of glucose-d7 on Enterococcus faecalis in the present application;
[0026] Fig.10 AF is the SRS metabolic imaging result of the antibiotic sensitivity test of Enterococcus faecalis 31970 after application of different antibiotics in this application;
[0027] Fig.11 AD describes the differentiation results of oxacillin-sensitive and resistant Staphylococcus aureus within 0.5 h;
[0028] Fig.12 The SRS imaging results and corresponding spectral data of the present application after 1 hour of cultivation in a medium containing glucose-d7;
[0029] Fig.13 AC is the SRS imaging result and corresponding spectral data of the present application after culturing in a medium containing glucose-d7 for 3 h;
[0030] Fig.14 The process of antibiotic susceptibility testing (AST) in this application;
[0031] Fig.15 A is the spontaneous Raman spectrum result of Pseudomonas aeruginosa in the present application after being cultured in normal medium and LB medium containing 70% D2O for 2 hours;
[0032] Fig.15 B is the temperature at 2162 cm2 in which Pseudomonas aeruginosa was cultured in normal medium and LB medium containing 70% D2O for 2 h. -1 The SRS imaging results of the CD area at and the corresponding transmission imaging results;
[0033] Fig.15 C is this application Fig.15 The SRS spectrum results corresponding to a single bacterium in B;
[0034] Fig.16 A is the Pseudomonas aeruginosa cultured in LB medium containing 70% D2O for 30 min, chirped with two SF57 glass rods, and then detected by picosecond SRS at 2162 cm -1Imaging results of SRS at
[0035] Fig.16 B is the application Fig.16 Intensity map of the dashed line on bacteria in A;
[0036] Fig.16 C is the chirp emission of Pseudomonas aeruginosa at 2162 cm after being cultured in LB medium containing 70% D2O for 30 min without chirp treatment. -1 Imaging results of SRS at
[0037] Fig.16 D is this application Fig.16 Intensity map of the dashed line on bacteria in C;
[0038] Fig.17 A is the SRS imaging result of the CD region of Pseudomonas aeruginosa cultured in LB medium containing 70% D2O within 0-3h in this application;
[0039] Fig.17 B is the application Fig.17 A magnified image;
[0040] Fig.17 C is this application Fig.17 A is a schematic diagram of the dynamic changes in the average SRS intensity of a single Pseudomonas aeruginosa, where the error bars represent the standard deviation (N>10);
[0041] Fig.17 D is this application Fig.17 In B, the intensity diagram of the dotted line on the bacteria after 10 min of action;
[0042] Fig.17 E is this application Fig.17 In B, the intensity diagram of the dotted line on the bacteria at 30 min of action;
[0043] Fig.18 A is the SRS imaging result of the CD region during the biosynthesis of D2O in Pseudomonas aeruginosa during culturing of Pseudomonas aeruginosa in LB medium containing 70% D2O for 0-3h in this application;
[0044] Fig.18 B is in this application Fig.18 The enlarged image of Pseudomonas aeruginosa in the rectangular frame of B;
[0045] Fig.18 C is this application Fig.18 A is a schematic diagram of the dynamic changes in the average SRS intensity of a single Pseudomonas aeruginosa, where the error bars represent the standard deviation (N>10);
[0046] Fig.18D is this application Fig.18 Intensity diagram of the dashed line on the bacteria at 10 min in B;
[0047] Fig.18 E is this application Fig.18 Intensity diagram of the dashed line on the bacteria at 30 min in B;
[0048] Fig.19 A is the concentration of Pseudomonas aeruginosa in this application after adding 20ug / ml gentamicin to LB medium containing 70% D2O at 2162cm -1 The SRS imaging results of the CD area at and the corresponding transmission imaging results;
[0049] Fig.19 B is the concentration of Pseudomonas aeruginosa in this application at 2162 cm after adding 20 ug / ml cefotaxime to LB medium containing 70% D2O. -1 SRS imaging results and transmission imaging results of the CD area at ;
[0050] Fig.19 CH is the average CD area SRS intensity graph of Pseudomonas aeruginosa in the present application after being treated with 70% D2O in LB medium without antibiotics (control group) and with gentamicin or cefotaxime for different time periods;
[0051] Fig. 20 A is the concentration of Pseudomonas aeruginosa in normal LB medium (control group) or LB medium containing 70% D2O with different concentrations of gentamicin added at 2162 cm -1 SRS imaging results and transmission imaging results of the CD area at ;
[0052] Fig. 20 B is the application Fig. 20 Average CD area SRS intensity map of a single Pseudomonas aeruginosa in A. DETAILED DESCRIPTION
[0053] The detailed description of various embodiments in the present invention refers to the accompanying drawings, which explain various embodiments and their implementation methods by way of example and in the best way, but are not limited to these ways. The present application describes these embodiments in detail to enable those skilled in the art to implement them, but it should be understood that other embodiments can be implemented without departing from the spirit and scope disclosed in the present application, and mechanical or other changes can be made. In addition, any reference to the singular includes multiple embodiments, and any reference to more than one component can include a singular embodiment. Similarly, the ordering of a device or component or the ordering of a part of a device, such as "first" and "second", is to make the present application clearer and easier to understand, and should not be interpreted as limiting or expressing meanings other than arbitrary distinctions. In addition, the enumeration of multiple embodiments having the described features is not intended to exclude other embodiments having additional features, or other embodiments combining different combinations of the described features.
[0054] Systems, methods, and computer program products are provided in various embodiments disclosed in the present application. References to "various embodiments," "one embodiment," "an embodiment," and "an example embodiment," etc., indicate that the description of the embodiment may include a particular feature, structure, or characteristic, but not every embodiment includes it, and these phrases do not necessarily refer to the same embodiment. In addition, when a particular feature, structure, or characteristic is described in conjunction with an embodiment, it should be considered to be within the knowledge of those skilled in the art when combined with other embodiments, whether or not explicitly described. After reading the specification, it should be obvious to those skilled in the relevant art how to implement the present invention in alternative embodiments.
[0055] refer to Figure 1A-1B, determining antibiotic sensitivity by Raman metabolic imaging. The imaging system includes any type of Raman imaging, including but not limited to stimulated Raman scattering imaging, coherent anti-Stokes Raman scattering imaging, or coherent Raman-induced Kerr effect imaging. In an exemplary embodiment, the present invention discloses a hyperspectral stimulated Raman scattering (SRS) imaging device. The imaging system disclosed in the present invention may include a light source 101. In an exemplary embodiment, the light source may be a dual-output femtosecond pulse laser (InSight DeepSee, Spectra-Physics) with a repetition rate of about 80MHz, but any suitable rate may be used. The light source 101 may be used for hyperspectral SRS imaging. Similarly, the imaging system may use monochromatic SRS imaging. A light source 101 (e.g., an adjustable laser 103) may be used to image in the CD vibration region. In an exemplary embodiment, the adjustable laser may be a 120-fs tunable laser tuned to about 847nm. In addition, a filter may be incorporated to clean up the laser beam. The beam 103 may be used as a pump beam. A second beam 105, for example a 220-fs laser centered at approximately 1040 nm. The second beam 105 can be used as a Stokes beam and can be modulated to 2.35 MHz by an acousto-optic modulator 107 (AOM, 1205-C, Isomet). Each beam can pass through one or more filters or lenses. Similarly, each beam can pass through a polarization beam splitter (PBS) 133. In an exemplary embodiment, a motorized translation stage 109 (T-LS28E, Zaber) can be installed in the pump path to tune the delay between the pump beam 103 and the Stokes beam 105. The two beams can use a combiner 111, and then the two beams can be chirped using one or more glass rods 113. In an exemplary embodiment, two glass rods with a length of approximately 15 cm can be used. Again, the glass rods can be SF57 glass rods.
[0056] In some example embodiments, the pulse duration of the pump beam and the Stokes beam after chirping is approximately between 1-2 ps, or between 1.3 ps and 1.9 ps. In an example embodiment, the pump beam and the Stokes beam can be approximately 1.9 ps and 1.3 ps, respectively. In other embodiments, the imaging system can be free of beam chirping. The pump beam 103 and the Stokes beam 105 are introduced into a laser scanning microscope having a scanning unit 115 and one or more lenses 117. In an example embodiment, the lens 117 can be an approximately 60x water objective lens (NA=1.2, UPlanApo / IR, Olympus) for focusing the laser onto the sample 119. An oil condenser 121 (NA=1.4, U-AAC, Olympus) can be used to collect the combined laser beam 120 from the sample 123. One or more filters 125 (HQ825 / 150m, Chroma) can be used to filter out the Stokes beam. The pump beam is detected by a photodiode 127 (S3994-01, Hamamatsu), whose loss signal can be extracted by a lock-in amplifier (HF2LI, Zurich Instrument). The system may include one or more mirrors to direct each beam through the various components of the device. In some example embodiments, one or more mirrors 129 may be a dichroic mirror 131. Figure 1B As shown, ΔW1 and ΔW2 indicate possible Raman peaks that can be detected by the exemplary imaging system disclosed in the present application. Each delay between the chirped pump beam and the Stokes beam can correspond to a molecular vibration mode detected by the imaging system.
[0057] The present application also relates to a sample preparation method for an exemplary imaging system, including but not limited to an SRS imaging system. Sample preparation can utilize a bacterial culture plate. In an exemplary embodiment, the culture plate can include an agarose gel plate for placing bacteria in a solution on a gel plate for real-time imaging. In some exemplary embodiments, the agarose gel plate can be prepared according to the following steps: (1) Add 1% agarose powder to a plastic tube containing approximately 2 ml of pure water; (2) Microwave heating for 20 seconds until the agarose powder is completely dissolved; (3) Use a pipette to take 10 ul of the heated agarose gel solution and add it to a coverslip; (4) Take another coverslip to flatten the gel agarose gel solution and sandwich the gel between two coverslips; (5) After 2 minutes, remove one of the two coverslips by sliding; (6) The agarose gel remaining on one of the coverslips solidifies to form an agarose gel plate.
[0058] The bacterial AST procedure disclosed in the present application detects the metabolic activity of bacteria by Raman imaging, such as stimulated Raman scattering (SRS), within one cell cycle (about 30 minutes). The imaging system can use chirped picosecond SRS to monitor the metabolic activity of deuterated glucose (such as glucose-d7) at the CD vibration frequency, and use the CD signal as a marker for AST.
[0059] Similarly, water can also be used for biomolecule synthesis in bacteria, and its metabolism can be monitored using heavy water (D20) at CD frequencies using Raman spectroscopy. Unlike glucose-d7, D20 itself does not have CD bonds, so the metabolic activity of D20 may provide a better control for rapid AST compared to glucose-d7. Using spontaneous Raman spectroscopy, the metabolic activity of D20 has been applied to imaging metabolically active bacteria. SRS imaging has an order of magnitude signal enhancement function, which can achieve high-speed imaging. In addition, D20 metabolic activity SRS imaging is a non-invasive and accurate method that can visualize the metabolic dynamics of mammalian cells and animals. The SRS imaging method based on the present application can determine the sensitivity of bacteria to antibiotics within about 10 minutes. The bacterial solution placed on an agarose gel plate can be detected by SRS imaging, and the bacterial solution can be cultured in broth, such as lysing broth (LB) (LB Broth, Sigma Aldrich), and the logarithmic growth phase can be reached in about 2 hours. The bacteria are then added to 2 ml of various types of culture media at a ratio of about 0.1:100-10:100. In an exemplary embodiment, it can be added to 2 ml of culture media, such as a special culture media, at a ratio of about 1:100. In some exemplary embodiments, D20 culture media or other special culture media, such as M9 culture media in which about 2% glucose-d7 is used as a carbon source in this article, can be used. M9 culture media was selected because it maximizes the signal within the CD vibration area. In order to detect the resistance of specific bacteria to an antibiotic, the antibiotic was added to a specific culture media at a concentration of 20ug / ml. After incubation for at least 30 minutes, about 500ul of the sample was centrifuged, washed twice with pure water, and then added to an agarose gel plate for imaging. Figure 1A The process of processing samples is demonstrated.
[0060] refer to Figure 2A-D, in order to determine the effectiveness of using antibiotics, the present application can be disclosed in an exemplary method, such as using vancomycin. Therefore, the method can be used to detect the effect of antibiotics on bacterial metabolism of glucose-d7. Vancomycin-sensitive (VSE) and vancomycin-resistant (VRE) enterococci can be first cultured in LB medium and grown to the logarithmic phase in about 2 hours. Then, VSE and VRE enterococci can be further cultured in M9 medium containing 2% glucose-d7 as the sole carbon source, and vancomycin is added to a final concentration of 20ug / ml ( Figure 2A ). Other embodiments may include various types of carbon sources used as the sole carbon source, or in combination with other carbon sources or nutrient sources. In an exemplary embodiment, 0-100% deuterium dioxide may be used as a nutrient source. Likewise, the carbon source may include a combination of deuterium dioxide and glucose-d7. The concentration needs to be selected because it is between the minimum inhibitory concentrations (MICs) of vancomycin for VSE (MIC is 1 ug / ml) and for VRE (MIC>100 ug / ml). For control purposes, VSE and VRE were cultured in a medium containing glucose-d7 without the addition of vancomycin ( Figure 2A After incubation for 30 min (0.5 h) to 3 h, each sample was centrifuged and washed twice in water before being added to an agarose gel plate for SRS imaging.
[0061] Figure 2B The results show that VSE and VRE in the CD vibration region (~2160 cm) after 30 min of incubation in the medium containing glucose-d7. -1 ). In the control group (No antibiotics), both VSE and VRE had strong CD signals, indicating that the bacteria had a high metabolic absorption activity for glucose-d7, and individual bacteria could be clearly observed. In the vancomycin treatment group (20ug / mlvancomycin), the CD signal intensity of a single VSE had dropped to about 1 / 3 of the CD signal intensity of a single VSE in the control group. Since the SRS signal intensity of glucose-d7 is proportional to its concentration, the reduced signal indicates less absorption of glucose-d7. In contrast, the CD signal intensity of a single VRE was similar to that of the control group, with Susceptible indicating sensitivity and Resistant indicating resistance.
[0062] Figure 2C and 2D Shows Figure 2AThe corresponding normalized SRS spectra of VSE and VRE are shown in Figure 1. All spectra showed a peak in the CD vibration region, but vancomycin treatment reduced the signal intensity of VSE compared with the control group, while the signal intensity of VRE remained unchanged with and without vancomycin treatment, which is consistent with the Figure 2B The SRS imaging results shown are consistent with those shown above, where the Raman shift (cm -1 ) indicates Raman shift. These results indicate that the metabolic activity of VSE and VRE responds differently to vancomycin treatment, and thus the sensitivity of VSE and VRE can be determined within 30 min, which is close to the duration of one cell cycle of E. faecalis. Similar effects were observed after 1 and 3 h of vancomycin treatment, thus demonstrating that E. faecalis is not sensitive to vancomycin AST results using the currently disclosed imaging methods.
[0063] To quantify the CD content of E. faecalis cells and the bacterial response to antibiotic treatment, multivariate curve resolution (MCR) analysis was applied Figure 3 CD content of hyperspectral SRS imaging data in AD. MCR is a bilinear model that decomposes the experimental data matrix containing the spectrum of each pixel into a concentration map and a principal component spectrum. With the initial estimated spectrum of each component as input, the alternating least squares algorithm is used to iteratively calculate and optimize the MCR until convergence is reached. The output of MCR contains the concentration map and spectrum of each component. Figure 3 As shown in AD, the spectrum of glucose-d 7 representing the CD component and the spectrum of gel representing the background were used as input components, where Intensity represents the signal intensity, Raman shift (cm -1 ) represents the Raman shift. After MCR analysis, the CD component can be clearly separated from the background and used to quantify the content of the collected SRS imaging data.
[0064] Although the present method generally discloses a hyperspectral SRS microscope for AST based on metabolic imaging, in another exemplary embodiment, the sample prepared by the improved method can be detected using a single-frequency SRS microscope. Before the improvement, the single-frequency SRS microscope was used to detect bacteria dried on glass to avoid the movement of bacteria during the measurement process, which caused strong noise in the SRS signal. Prepare an agarose gel sample and deposit the bacteria in the solution on an agarose gel plate without killing the bacteria, thus removing the noise. In this way, the SRS signal of the bacteria at the CD vibration frequency mainly comes from the CD component. Therefore, the AST method based on metabolic imaging, which is performed by monitoring the changes in the CD components of bacteria, can be detected by single-frequency SRS imaging, which takes much less time than hyperspectral SRS imaging because only one image is taken instead of a bunch of images.
[0065] In addition, another exemplary embodiment may use additional steps to prepare the sample. In one exemplary embodiment, the sample for SRS imaging is prepared by drying bacteria on glass. Figure 4 As shown in ab, bacterial deposition on agarose gel can significantly reduce the cross-phase modulation noise of SRS imaging. Figure 4 a is bacteria grown in normal medium and dried on glass (Dried bacteria) at 2178cm -1 The SRS imaging results at Figure 4 b is bacteria cultured in normal culture medium and deposited on agarose gel plate (Bacteria on agarose gel) at 2178cm -1 SRS imaging results at . Strong background was observed when imaging with dried bacteria on glass, which may be due to cross-phase modulation. Live bacteria imaging can be performed using agarose gel plates in which the bacteria are deposited in solution. Figure 4 As shown in Figure B, this sample preparation greatly reduced the background of SRS imaging. To maximize the CD signal level, the culture medium was replaced from LB medium containing normal glucose to a customized M9 medium in which glucose-d7 was the only carbon source, and the concentration of glucose-d7 was increased to 2%. To ensure signal and spectral resolution, two 15 cm long SF57 glass rods were used to chirp the pump beam and Stokes beam for hyperspectral SRS imaging, and the signal-to-noise ratio of a single bacterium reached about 5 in the CD vibration region, and the spectral resolution was about 20 cm -1 .
[0066] To test the toxicity of glucose-d7 on bacteria, E. faecalis 31970 and 31972 were cultured in customized M9 medium, one with normal glucose as a control and the other with glucose-d7. The growth of bacteria was monitored by measuring the optical density (OD) at 600 nm until 22 h ( Fig. 9 Two similar growth curves were observed when Enterococcus faecalis 31970 and 31972 were cultured in normal medium (Glucose) and medium containing glucose-d7 (Glucose-d7), indicating that glucose-d7 did not have any toxicity to bacterial growth. Fig. 9 A shows the OD value of vancomycin-sensitive enterococci in M9 medium containing 2% normal glucose or 2% glucose-d7. Fig. 9 B shows the OD values of vancomycin-resistant Enterococci in M9 medium containing 2% normal glucose or 2% glucose-d7.
[0067] MIC can be defined as the lowest antibiotic concentration that can inhibit visible bacterial growth in vitro and can be determined by our metabolic imaging method. VSE were cultured in M9 medium containing glucose-d7 plus different concentrations of vancomycin. After 1 h of culture, each sample was centrifuged, washed twice with PBS, and deposited on agarose gel plates for SRS imaging. Figure 5A The CD components of each sample after MCR analysis are shown. To quantitatively compare the uptake of glucose-d7 in bacteria treated with vancomycin, the CD component intensities of individual bacteria in the field of view were statistically analyzed and plotted ( Figure 5B ), where E.faecalis 31970 indicates enterococcus 31970 and Intensity indicates signal intensity. Treatment with vancomycin at a concentration of 2ug / ml or higher significantly reduced the intensity of the CD component compared with the control group that was not treated with vancomycin. In contrast, 1ug / ml vancomycin did not reduce this intensity. Therefore, the MIC value of VSE determined by our metabolic imaging method was 2ug / ml, which was twice the MIC value determined based on the traditional culture method. This difference is acceptable and within the range of precision, which is largely due to the manual serial dilution of antibiotics in conventional AST. Figure 5A Shown are the results of CD component concentration plots of bacteria cultured in medium containing glucose-d7 for 1 h in the presence of different vancomycin concentrations. Figure 5B The figure is a quantitative graph of CD component intensity. Compared with the control group not treated with vancomycin, the CD component intensity of bacteria treated with 2ug / ml and higher concentrations of vancomycin showed a significant decrease. Figure 5C As shown, MIC values determined by traditional culture-based methods and our metabolic imaging approach were compared.
[0068] To evaluate the metabolic activity of bacteria, E. faecalis was cultured in medium containing normal glucose 801 and glucose-d7803, and then washed away with PBS and deposited on agarose gel plates for SRS imaging. Figure 7 As shown in B, the hyperspectral SRS imaging results of 1M glucose-d7 solution show that the CD vibration mode at 2130 cm -1 This peak is located in the cell-silent region of the Raman spectrum, providing a good control for metabolic absorption imaging of deuterium-labeled metabolites. SRS imaging of bacteria cultured in medium containing glucose-d7 showed a strong signal in the CD vibration region, indicating that the bacteria successfully absorbed and utilized glucose-d7. As a control, no signal was observed in bacteria cultured in normal glucose medium. Figure 8These conclusions were further confirmed by spontaneous Raman measurements, where a peak was observed only in the CD region for bacteria cultured in glucose-d7 medium (803). Together, these data suggest that bacterial metabolic activity in response to glucose-d7 uptake can be monitored at the single cell level by hyperspectral SRS imaging. The gray bar 805 indicates the 2150 cm -1 CD area nearby.
[0069] Figure 6 AD depicts the results of changes in CD components in bacteria cultured in medium containing glucose-d7 in the presence and absence (No antibiotics) of 20ug / ml vancomycin, where Intensity represents signal intensity. Figure 6 A and 6B show the temporal dynamics of CD components after MCR analysis of VSE and VRE, respectively. The average intensity of CD components in individual bacteria was quantified and plotted on the cells representing VSE and VRE, respectively. Figure 6 C and 6D. For the VSE control group not treated with vancomycin, bacteria cultured in glucose-d 7 medium for about 0.5 h and 1 h had similar CD component intensities, while the CD component intensity of bacteria cultured for 3 h was higher ( Figure 6 C), indicating a slight increase in glucose-d 7 uptake over time. For the VSE control group, single bacteria cultured for approximately 0.5 h to 3 h had similar CD component intensities ( Figure 6 D). Vancomycin treatment significantly reduced the intensity of the CD component of VSE. The t-test was used to analyze the significance between the VSE control group and the treatment group. The p values at 0.5h, 1h, and 3h were 2.2×10 -13 , 2.0×10 -11 and 3.9×10 -15 Vancomycin treatment did not significantly reduce the intensity of CD components in the VRE group. Interestingly, the intensity of CD components in VRE treated with vancomycin for 3 h was higher than that in the control group (p value was 5x10 -4 ), which is likely attributed to the metabolic response of VRE to vancomycin treatment, whereby the cells increased their uptake of glucose to relieve antibiotic pressure. The results showed that within 3 hours, vancomycin treatment significantly reduced the uptake of glucose-d7 by VSE, but not by VRE. Therefore, the sensitivity of VSE and VRE to vancomycin can be rapidly determined. Fig.12 AC depicts the corresponding data and imaging data of bacteria cultured in medium containing glucose-d7 for 1 h. Fig.12A shows the SRS imaging results of the CD vibration area of vancomycin-sensitive and -resistant enterococci cultured in a medium containing glucose-d7 and treated with or without 20ug / ml vancomycin. Fig.12 B shows the corresponding spectra of vancomycin-sensitive enterococci when 1203 is treated with vancomycin and 1201 is not treated with vancomycin (Control). Fig.12 C shows the corresponding spectra of vancomycin-susceptible enterococci treated with and without vancomycin, indicating that the imaging data were not shifted. Fig.13 AC represent the corresponding data and imaging data of bacteria cultured in medium containing glucose-d7 for 3 h, respectively. Fig.13 B shows the corresponding spectra of vancomycin-susceptible enterococci 1303 treated with vancomycin and 1301 not treated with vancomycin. Fig.13 C shows the corresponding spectra of vancomycin-susceptible enterococci with and without vancomycin treatment, indicating that there is no shift in the imaging data.
[0070] We performed additional tests to determine whether metabolic imaging based on the AST method is applicable to other antibiotics. VSE Enterococcus 31970 was cultured in M9 medium containing glucose-d7 and 5 different antibiotics were added, including vancomycin, linezolid, daptomycin, gentamycin, and erythromycin. These antibiotics are commonly prescribed in the clinic for bacterial infections and have different mechanisms of action. Fig.10 AF shows the SRS imaging results of VSE after 1 h of culture in medium containing glucose-d7 without antibiotic treatment (control group) and with various antibiotics at a final concentration of 20 ug / ml. A significant decrease in CD signal was observed only in bacteria treated with vancomycin and linezolid. Therefore, based on our metabolic imaging method, it can be concluded that Enterococcus faecalis 31970 is sensitive to vancomycin and linezolid, but resistant to daptomycin, gentamicin and erythromycin. The MIC values of these antibiotics for VSE were determined by conventional culture methods, and the results are shown in Table 1 below. The sensitivity of VSE to these five antibiotics is consistent with the results determined by our metabolic imaging method.
[0071] Table 1 MIC (ug / ml) values of various antibodies against Enterococcus faecalis 31970
[0072] antibiotic Gentamycin Linezolid Erythromycin Vancomycin Daptomycin MIC (ug / ml) >256 2 >256 1 32
[0073] To verify that this method is applicable to other bacteria, a sensitive strain resistant to oxacillin (MIC 0.0625ug / ml), Staphylococcus aureus, was used for testing. By SRS imaging, the metabolic activity of glucose-d7 can be observed in single bacteria cultured in medium containing glucose-d7 for 0.5h ( Fig.11 B). When the bacteria were treated with 1.3ug / ml oxacillin for 0.5h, the CD peak of the susceptible strain 1103 was reduced compared with the control 1101 not treated with oxacillin ( Fig.11 C), no significant changes were observed in the resistant strains ( Fig.11 D). Therefore, sensitive and resistant S. aureus can be identified in approximately 0.5 hours.
[0074] The present application further provides a metabolic imaging method, which can determine the sensitivity and MIC value of live bacteria to antibiotics by monitoring the metabolic activity of bacteria at the single cell level within about 30 minutes. This method can reduce the time required for AST from at least 16h to 24h based on traditional culture methods to 0.5h. AST at the level of single bacteria based on metabolic imaging is particularly suitable for bacteria that cannot be cultured or difficult to cultivate, because metabolic activity grows faster than phenotypic activity, and bacteria may not need to replicate to detect the response of metabolic activity to antibiotic treatment.
[0075] SRS imaging of D2O is demonstrated using Pseudomonas aeruginosa to demonstrate metabolic activity of heavy water. For broad spectrum CD vibrational spectroscopy, the signal of the bacteria can be improved by about 5 times more by femtosecond SRS without chirping compared to chirped SRS. D2O metabolism in bacteria may respond differently to different antibiotics, as fast as about 10 minutes, depending on the sensitivity of the individual bacteria studied for metabolic activity using SRS microscopy, and sensitivity to rapid AST that generally works on different bacteria.
[0076] First, the toxicity of D2O to bacteria was tested by the growth of bacteria in a medium containing D2O. Three types of bacteria (E. coli, Staphylococcus aureus, and Pseudomonas aeruginosa) were cultured in LB medium containing different concentrations of D2O, and their growth was monitored by measuring the optical density (OD) at about 600nm. D2O concentrations up to 100% did not show obvious toxicity to the growth of E. coli and Staphylococcus aureus, as shown in the growth curves in various concentrations of D2O medium ( Fig.15AB). The growth of P. aeruginosa initially slowed down in LB medium with D2O concentrations above 70%, but eventually returned to normal growth after about 18 hours in medium with D2O concentrations of 70% and 80% and about 22 hours in medium with D2O concentration of 100% ( Fig.15 c). Therefore, D2O in the culture medium will not have significant toxicity to bacteria.
[0077] Bacteria were cultured in LB medium with a D2O concentration of 70%, and Pseudomonas aeruginosa was used as a model to test whether the metabolic activity of D2O in a single bacterium can be monitored by SRS microscopy. Pseudomonas aeruginosa was cultured in normal LB medium (Normal LB) and LB medium containing 70% D2O for about 2 hours, then centrifuged and washed with water to remove the medium. Fig.16 A, Bacteria cultured in a medium containing D2O. The spontaneous Raman spectrum of high-density bacteria in the CD vibration region shows a peak at about 2070 cm -1 To about 2250cm -1 There is a broad peak 1601 between the two, which indicates that D2O has been successfully used for biomolecule synthesis. In the control group, bacteria 1603 cultured in normal culture medium did not show this peak in this region ( Fig.16 A). To image individual bacteria, the bacteria were further diluted and deposited on an agarose gel plate. By tuning the SRS frequency to approximately 2162 cm -1 In the CD region, a strong signal of a single bacterium cultured in the medium containing D20 can be observed ( Fig.16 B, right). As a control, no CD signal was observed in bacteria cultured in normal medium ( Fig.16 B, left). This result is also seen in the SRS spectra obtained by temporal modulation of chirped pumping and Stokes femtosecond pulses ( Fig.16 C) has been confirmed.
[0078] To further improve the CD signal of individual bacteria, non-chirped femtosecond pulses were tested to improve the signal-to-noise ratio (SNR) of chirped picosecond pulses. -1 Width( Fig.16 C), so femtosecond SRS without chirp may further increase the SNR. To this end, we cultured P. aeruginosa in LB medium containing 70% D20 for 30 min and then excited the cells with chirped picosecond pulses and non-chirped femtosecond pulses at 2162 cm -1 The results are shown in Fig.17 A and Fig.17C, where 2rods means chirping with 2 SF57 glass rods, and No rods means no chirping. The pump and Stokes powers were adjusted to ensure that the same average pump and Stokes powers were used on the sample. The signal-to-noise ratio (SNR) of a single bacterium for picosecond and femtosecond SRS was 1.43 and 7.81, respectively, indicating that the SNR of femtosecond SRS was improved by about 5.44 times compared with that of picosecond SRS. Fig.17 B and 17D, where pixels denotes pixels. This improvement can be attributed to two different aspects of the setup. One is that the CD vibration band is very wide, and femtosecond SRS can detect a wider band signal than chirped picosecond SRS. Second, chirped pulses can reduce the peak power of the pulse. Although the same average power is used on the sample, the reduced peak power will significantly reduce the SNR due to the nonlinear effects of SRS.
[0079] Femtosecond SRS imaging can detect the changes in D20 metabolic activity in a single Pseudomonas aeruginosa. First, Pseudomonas aeruginosa was cultured in LB medium containing about 70% D20 for about 3 hours. At different time points, about 500ul of bacteria were taken out for centrifugation, washed and deposited on an agarose gel plate for imaging. Fig.18 A shows that at 2162cm -1 SRS imaging of a single Pseudomonas aeruginosa was performed at 100 nm, and the CD signal of a single Pseudomonas aeruginosa was observed after only about 10 minutes. Statistical analysis showed that the average CD signal intensity of a single bacterium increased over time and reached saturation at about 1.5 hours. Fig.18 C, this is because the generation time of Pseudomonas aeruginosa cultured in LB medium is 24-27min, which is about three generations. In order to observe individual bacteria more clearly, Fig.18 The image in A is Fig.18 It is further magnified in B. Interestingly, Fig.18 B shows the result after 10 minutes. A stronger signal was observed at the periphery of the bacterial cells. Fig.18 Bacterial intensity graph shown in D. In contrast, within 30 min and after 30 min, Fig.17 B shows that the signal intensity is stronger in the center of the bacterial cell. Fig.18 Bacterial intensity plot over 30 min shown in E. Overall, these results suggest that water is initially used to synthesize the cell membrane and / or cell wall of P. aeruginosa.
[0080] Pseudomonas aeruginosa was cultured in LB medium containing 70% D20 and supplemented with 20ug / ml gentamicin or cefotaxime to determine the effect of antibiotics on D20 metabolic activity in bacteria, and this situation is also suitable for rapid AST using SRS imaging. Using the traditional culture-based microdilution method, the sensitivity of Pseudomonas aeruginosa was previously determined to be sensitive to gentamicin and resistant to cefotaxime at this concentration. Fig.19 As shown in A, at 2162cm -1 SRS imaging at 2162 cm-1 showed that the CD signal decreased significantly after the addition of 20 ug / ml gentamicin, indicating that gentamicin inhibited the metabolic activity of Pseudomonas aeruginosa D20. In contrast, after the addition of cefotaxime to Pseudomonas aeruginosa, the CD signal at about 2162 cm-1 decreased significantly at all time points. -1 It can be observed in the SRS imaging at all locations, indicating that when cefotaxime is added to the culture medium, the D20 of Pseudomonas aeruginosa has active metabolic activity. We observed that when cefotaxime is added to the culture medium, Pseudomonas aeruginosa tends to form long rods, such as Fig.19 As shown in Figure B, this may be because cefotaxime is a β-lactam antibiotic that inhibits the synthesis of bacterial cell walls, so Pseudomonas aeruginosa can still grow but cannot divide when cefotaxime is added to the culture. This filamentous structure can also be observed when Pseudomonas aeruginosa is treated with other β-lactam antibiotics10.
[0081] The D20 metabolic activity of bacteria can be used to quickly distinguish the antibiotic sensitivity of bacteria and is detected using the average CD signal intensity of the bacteria. Fig.19 CH compared the three groups, where Ctrl represented the control group, Gen represented the gentamicin-treated group, and Cef represented the cefotaxime-treated group. Fig.18 A), gentamicin-treated group ( Fig.19 A) and cefotaxime-treated group ( Fig.19 B) To separate the sensitive group from the resistant group, we determined a linear threshold of about 65%, which was 65% of the average CD intensity of the bacteria in all result graphs of the control group from about 10 min to 3 h. Fig.19 As shown in CH. This threshold can clearly distinguish the sensitive group from the resistant group. At all time points, the group treated with gentamicin was always below the threshold, while the group treated with cefotaxime was always above the threshold. Therefore, the sensitivity of Pseudomonas aeruginosa to gentamicin and cefotaxime can be determined in just 10 minutes.
[0082] The SRS metabolic imaging method can determine the minimum inhibitory concentration (MIC) of antibiotics against bacteria. This test is performed by culturing Pseudomonas aeruginosa in LB medium containing about 70% D20 for about 1 hour and adding serially diluted concentrations of gentamicin. Fig. 20 As shown in A, at 2162cm -1 The SRS imaging at 100 μg / ml showed that the D20 metabolic activity of Pseudomonas aeruginosa was inhibited when gentamicin at a concentration of 8 μg / ml or higher was added. In the control group, no CD signal was observed for Pseudomonas aeruginosa cultured in normal LB medium. The average intensity of the CD signal of Pseudomonas aeruginosa was plotted and compared, as shown in Figure 2. Fig. 20 As shown in B. Under the condition of an intensity threshold of 65%, the MIC determined by the SRS-based D20 metabolic imaging method was approximately 8ug / ml, which was consistent with the results determined by the conventional culture-based method.
[0083] Without departing from the spirit and scope of the present invention, a variety of other layouts can be easily designed by those skilled in the art. In addition, the principles of the present invention described herein, various aspects and embodiments and specific embodiments are intended to cover their structural and functional equivalents. In addition, it is expected that such equivalents include currently known equivalents and equivalents developed in the future, that is, any element that performs the same function, regardless of structure. All references cited herein are incorporated by reference. Additional disclosures are found in Appendix A, the entire contents of which are incorporated herein by reference.
Claims
1. A method for determining the sensitivity of bacteria to antibiotics, characterized in that: include: Step 1, preparing a bacteria-immobilized gel, and culturing the bacteria in a culture medium with a nutrient source; Step 2, adding a preselected antibiotic to the culture medium; Step 3, incubating the antibiotic and bacteria in a culture medium for a predetermined period of time to form a sample; Step 4, centrifuging the sample; Step 5, washing the sample; Step 6, depositing the sample on the bacteria immobilization gel; Step 7, collecting an image of the sample on the bacteria immobilized gel by coherent Raman microscopy, wherein the immobilized gel is composed of agarose gel; The coherent Raman microscope is a hyperspectral coherent Raman microscope or a single-frequency coherent Raman microscope. The hyperspectral coherent Raman microscope includes a hyperspectral stimulated Raman scattering imaging device, the device includes: a dual-output femtosecond pulse laser with a repetition rate of 80 MHz, and the dual-output femtosecond pulse layer includes: Pump beam; Stokes beam; The Stokes beam path is modulated by an acousto-optic modulator; The pump beam path has a translation stage to tune the delay between the pump beam and the Stokes beam; a combiner for combining the pump beam and the Stokes beam; a laser scanning microscope having an objective lens for focusing the pump beam and the Stokes beam on the sample; an oil condenser for collecting laser light from the sample; an optical filter, the optical filter being located after the oil condenser and used for filtering out the Stokes beam; a photodiode, the photodiode being located after the optical filter and used for detecting the pump beam; a lock-in amplifier for extracting the pump beam signal loss, A chirp device is also included, and the chirp device is used to form different pulse durations between the Stokes beam and the pump beam.
2. The method for determining the sensitivity of bacteria to antibiotics according to claim 1, characterized in that: The nutrient source has a single carbon source, which consists of only 0.1-10% glucose-d7.
3. The method for determining the sensitivity of bacteria to antibiotics according to claim 1, characterized in that: The nutrient source consists of culture medium containing 0-100% deuterium dioxide.
4. The method for determining the sensitivity of bacteria to antibiotics according to claim 1, characterized in that: The nutrient source consists of glucose-d7 and deuterium dioxide.
5. The method for determining the sensitivity of bacteria to antibiotics according to claim 1, characterized in that: The image of the sample collected by the Raman microscope is Raman imaging, and the Raman imaging is stimulated Raman scattering imaging, coherent anti-Stokes Raman scattering imaging or coherent Raman-induced Kerr effect imaging.
6. The method for determining the sensitivity of bacteria to antibiotics according to claim 1, characterized in that: The chirp device is two 15 cm long SF57 glass rods.
7. The method for determining the sensitivity of bacteria to antibiotics according to claim 1, characterized in that: Use a pair of filters.
8. The method for determining the sensitivity of bacteria to antibiotics according to claim 1, characterized in that: The objective lens of the laser scanning microscope is a 60-fold water objective lens.
9. The method for determining the sensitivity of bacteria to antibiotics according to claim 1, characterized in that: The pulse duration of the pump beam is between 1.5 and 2 ps, and the pulse duration of the Stokes beam is between 1.0 and 1.4 ps.
10. The method for determining the sensitivity of bacteria to antibiotics according to claim 1, characterized in that: The chirp device is used to form a pulse duration of 1.9 ps for the pump beam and 1.3 ps for the Stokes beam.
11. The method for determining the sensitivity of bacteria to antibiotics according to claim 1, characterized in that: The pump beam is a 120-fs tunable laser with a pump beam path, and the Stokes beam is a 220-fs laser with a Stokes beam path centered at 1040 nm.
12. A method for rapidly determining the sensitivity of bacteria to antibiotics using a microscope, characterized in that: include: growing bacteria in a medium with a nutrient source; adding an antibiotic having a preselected concentration to the culture medium to form a sample; incubating the sample in the culture medium for a predetermined period of time; Centrifuge the sample; Wash the sample; The samples were deposited on the bacteria-immobilized gel; imaging the bacterial sample on the immobilized gel using a coherent Raman microscope including a stimulated Raman scattering system; The stimulated Raman scattering system uses a pump beam and a Stokes beam, which are chirped with one or more glass rods to produce a pulse duration of 1-2 ps between the pump beam and the Stokes beam; The coherent Raman microscope also includes a translation stage for tuning the delay between the pump beam and the Stokes beam.
